15 /100
LOW RISK
Score updated Jul 14, 2026

BAM — Brookfield Asset Management Ltd. Dilution Risk Tracker

Track BAM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BAM — Get alerts when the score changes →

As of July 14, 2026, Brookfield Asset Management Ltd. (BAM) has a DilutionWatch DilutionScore of 15/100, rated LOW dilution risk. Brookfield Asset Management Ltd. has a market capitalization of $77.60B, 399.60M shares outstanding, 634 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BAM.
🔔 Track BAM — Get forecast alerts →

💹 Market Data

Market Cap$77.60B
Shares Outstanding399.60M
Float320.97M
Cash$1.04B
Debt$2.95B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 0.9% shares (2026Q1 vs prior)
634 institutional holders · 1.52B shares
#1 BROOKFIELD Corp /ON/ 1.19B shares
#2 Partners Value Investments L.P. 29.59M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 23.13M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest18.84M
Days to Cover5.8
% of Float5.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

8-K 8K EVENT Apr 17, 2026
8-K 8K EVENT Apr 16, 2026
8-K 8K EVENT Apr 15, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Mar 24, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BAM Shareholders

Brookfield Asset Management Ltd. (BAM) has a DilutionScore of 15/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for BAM shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BAM in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for BAM alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BAM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BAM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BAM
📊 BAM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BAM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.